BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15289440)

  • 1. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
    Hollenbach E; Neumann M; Vieth M; Roessner A; Malfertheiner P; Naumann M
    FASEB J; 2004 Oct; 18(13):1550-2. PubMed ID: 15289440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.
    Hollenbach E; Vieth M; Roessner A; Neumann M; Malfertheiner P; Naumann M
    J Biol Chem; 2005 Apr; 280(15):14981-8. PubMed ID: 15691843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
    Kim HJ; Lee HS; Chong YH; Kang JL
    Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases.
    Malamut G; Cabane C; Dubuquoy L; Malapel M; Dérijard B; Gay J; Tamboli C; Colombel JF; Desreumaux P
    Dig Dis Sci; 2006 Aug; 51(8):1443-53. PubMed ID: 16838116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.
    Liu S; Feng G; Wang GL; Liu GJ
    Eur J Pharmacol; 2008 Apr; 584(1):159-65. PubMed ID: 18328478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of p38 mitogen activated protein kinase inhibitor SB203580 on colonic mucosa tumor necrosis factor alpha expression in ulcerative colitis].
    Yi WQ; Gan HT; Huang XL; Zhang M; Ouyang Q
    Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):747-50. PubMed ID: 18028805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy.
    O'Sullivan AW; Wang JH; Redmond HP
    J Surg Res; 2009 Mar; 152(1):46-53. PubMed ID: 19027920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model.
    Dong X; Liu Y; Du M; Wang Q; Yu CT; Fan X
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):77-84. PubMed ID: 16723252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 mitogen-activated protein kinase inhibition attenuates burn-induced liver injury in rats.
    Chen XL; Xia ZF; Yu YX; Wei D; Wang CR; Ben DF
    Burns; 2005 May; 31(3):320-30. PubMed ID: 15774288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection.
    Zhang J; Wu XY; Yu FS
    Curr Eye Res; 2005 Jul; 30(7):527-34. PubMed ID: 16020286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
    Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
    Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of MAPK and NF-κ B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease.
    Liu W; Liu Y; Wang Z; Yu T; Lu Q; Chen H
    Pharmazie; 2015 Sep; 70(9):598-603. PubMed ID: 26492645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
    Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
    Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol selectively inhibits nuclear factor-κB activity by suppressing p38 mitogen-activated protein kinase signaling in human EA.hy926 endothelial cells during intermittent hypoxia/reoxygenation.
    Li D; Wang C; Li N; Zhang L
    Mol Med Rep; 2014 Apr; 9(4):1460-6. PubMed ID: 24535078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation.
    Dufner A; Pownall S; Mak TW
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):988-93. PubMed ID: 16418290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
    Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
    Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes.
    Dai X; Sayama K; Tohyama M; Shirakata Y; Yang L; Hirakawa S; Tokumaru S; Hashimoto K
    Int Immunol; 2008 Jul; 20(7):901-9. PubMed ID: 18492658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of p38 mitogen-activated protein kinase pathway in pathogenesis of ulcerative colitis].
    He FQ; Zou YP; Huang XL; Gao FJ; Peng L; Gan HT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):393-6, 401. PubMed ID: 23898520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.